Recent Progress in Histone Demethylase Inhibitors

被引：144
|
作者：
McAllister, Tom E. [1 ,2 ]
England, Katherine S. [3 ,4 ]
Hopkinson, Richard J. [1 ]
Brennan, Paul E. [3 ,4 ]
Kawamura, Akane [1 ,2 ]
Schofield, Christopher J. [1 ]
机构：
[1] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England
[2] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Old Rd Campus,Roosevelt Dr, Headington OX3 7BN, England
[3] Univ Oxford, Struct Genom Consortium, Old Rd Campus,Roosevelt Dr, Headington OX3 7DQ, England
[4] Univ Oxford, Target Discovery Inst, NDM Res Bldg,Roosevelt Dr, Headington OX3 7FZ, England
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2016年 / 59卷 / 04期
基金：
加拿大创新基金会; 英国惠康基金; 巴西圣保罗研究基金会; 英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词：
PROTEIN LYSINE METHYLATION; LSD1; INHIBITORS; STRUCTURAL BASIS; CANCER-CELLS; CYCLOPROPYLAMINE DERIVATIVES; ASPARAGINYL HYDROXYLASE; SELECTIVE-INHIBITION; LYSYL-HYDROXYLATION; BIOLOGICAL-ACTIVITY; MENTAL-RETARDATION;
D O I：
10.1021/acs.jmedchem.5b01758
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
There is increasing interest in targeting histone N-methyl-lysine demethylases (KDMs) with small molecules both for the generation of probes for target exploration and for therapeutic purposes. Here we update on previous reviews on the inhibition of the lysine-specific demethylases (LSDs or KDM1s) and JmjC families of N-methyl-lysine demethylases (JmjC KDMs, KDM2-7), focusing on the academic and patent literature from 2014 to date. We also highlight recent biochemical, biological, and structural studies which are relevant to KDM inhibitor development.
引用
收藏
页码：1308 / 1329
页数：22
相关论文
共 50 条
  • [1] Histone Lysine Demethylase Inhibitors
    Jambhekar, Ashwini
    Anastas, Jamie N.
    Shi, Yang
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [2] Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
    Cappellacci, Loredana
    Perinelli, Diego R.
    Maggi, Filippo
    Grifantini, Mario
    Petrelli, Riccardo
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (15) : 2449 - 2493
  • [3] Advances in the development of histone lysine demethylase inhibitors
    Maes, Tamara
    Carceller, Elena
    Salas, Jordi
    Ortega, Alberto
    Buesa, Carlos
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 52 - 60
  • [4] Histone lysine specific demethylase 1 inhibitors
    Mehndiratta, Samir
    Liou, Jing-Ping
    RSC MEDICINAL CHEMISTRY, 2020, 11 (09): : 969 - 981
  • [5] Selective histone deacetylase small molecule inhibitors: recent progress and perspectives
    Qin, Hai-Tao
    Li, Huan-Qiu
    Liu, Feng
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (05) : 621 - 636
  • [6] Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent
    Patel, Preeti
    Wahan, Simranpreet K.
    Vishakha, S.
    Das Kurmi, Balak
    Das Gupta, Ghanshyam
    Rajak, Harish
    Asati, Vivek
    CURRENT CANCER DRUG TARGETS, 2023, 23 (01) : 47 - 70
  • [7] Identification of catechols as histone-lysine demethylase inhibitors
    Nielsen, Anders L.
    Kristensen, Line H.
    Stephansen, Karen B.
    Kristensen, Jan B. L.
    Helgstrand, Charlotte
    Lees, Michael
    Cloos, Paul
    Helin, Kristian
    Gajhede, Michael
    Olsen, Lars
    FEBS LETTERS, 2012, 586 (08) : 1190 - 1194
  • [8] Assessing histone demethylase inhibitors in cells: lessons learned
    Stephanie B. Hatch
    Clarence Yapp
    Raquel C. Montenegro
    Pavel Savitsky
    Vicki Gamble
    Anthony Tumber
    Gian Filippo Ruda
    Vassilios Bavetsias
    Oleg Fedorov
    Butrus Atrash
    Florence Raynaud
    Rachel Lanigan
    LeAnne Carmichael
    Kathy Tomlin
    Rosemary Burke
    Susan M. Westaway
    Jack A. Brown
    Rab K. Prinjha
    Elisabeth D. Martinez
    Udo Oppermann
    Christopher J. Schofield
    Chas Bountra
    Akane Kawamura
    Julian Blagg
    Paul E. Brennan
    Olivia Rossanese
    Susanne Müller
    Epigenetics & Chromatin, 10
  • [9] The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
    Spannhoff, Astrid
    Hauser, Alexander-Thomas
    Heinke, Ralf
    Sippl, Wolfgang
    Jung, Manfred
    CHEMMEDCHEM, 2009, 4 (10) : 1568 - 1582
  • [10] Assessing histone demethylase inhibitors in cells: lessons learned
    Hatch, Stephanie B.
    Yapp, Clarence
    Montenegro, Raquel C.
    Savitsky, Pavel
    Gamble, Vicki
    Tumber, Anthony
    Ruda, Gian Filippo
    Bavetsias, Vassilios
    Fedorov, Oleg
    Atrash, Butrus
    Raynaud, Florence
    Lanigan, Rachel
    Carmichael, LeAnne
    Tomlin, Kathy
    Burke, Rosemary
    Westaway, Susan M.
    Brown, Jack A.
    Prinjha, Rab K.
    Martinez, Elisabeth D.
    Oppermann, Udo
    Schofield, Christopher J.
    Bountra, Chas
    Kawamura, Akane
    Blagg, Julian
    Brennan, Paul E.
    Rossanese, Olivia
    Mueller, Susanne
    EPIGENETICS & CHROMATIN, 2017, 10
12345